Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €3.2M.
Filing timeline
BuySaleInsider track record
Dilip Singh Rathore: trading record in brief
Dilip Singh Rathore appears in 24 filings for JB Chemicals & Pharmaceuticals Limited, an Indian company listed on the Bombay stock exchange, under the title Employees/Designated Employees, published between August 23, 2022 and January 23, 2026.
The record counts 5 sales worth EUR 1,116,247 in total, with a median of EUR 82,258. Two dominate: EUR 541,849 on December 19, 2024 and EUR 357,971 on December 4, 2025, ahead of the one of February 16, 2024 (EUR 82,258). No purchase. Half of the filings, 12, are of another kind, and 7 are grants.
The yearly pace is modest: 3 filings in 2022, 5 in 2023, 7 in 2024 and 2025, 2 in 2026. Five filings fall in the last twelve months, one of them a sale.
Filings are published a median of 1 day after the trade (24 dated filings). The count of trades by Rathore within 30 days of colleagues at JB Chemicals & Pharmaceuticals Limited is 4, 4 and 3, all in the same direction. Colleagues in order: Mitesh Kothari, Nikhil Chopra and Kunal Khanna.
Companies and markets linked to Dilip Singh Rathore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 217,534 shares@ ₹1,600.0023.7% of flowEquity SharesSEBI:9ff3aa4dad9e89982b42ac6a980aef508b225132
- 217,534 shares@ ₹1,884.6028.2% of flowEquity SharesSEBI:647c02b598ee449fbac9e4fb3857bb6d8163498f
- 21,056 shares@ ₹1,789.94572.6% of flowEquity SharesSEBI:30d3b457d76963fc17951453e4af89807ac72c5e
- 21,056 shares@ ₹1,777.402.6% of flowEquity SharesSEBI:491541c3e4ba86a20ee713131c5b5ced1a72d9d9
- 21,056 shares@ ₹1,729.602.6% of flowEquity SharesSEBI:6f75316df6c5fba61ea34c4d13b820e6e65ecd99
- 11,607 shares@ ₹1,700.36681.5% of flowEquity SharesSEBI:ed1c221da9bf7eec59454f58fd6ff50e3ec330d5
- 22,322 shares@ ₹1,700.79642.9% of flowEquity SharesSEBI:4eab1ae37387f50cf13b89f04527acba8aa0cb9b
- 37,590 shares@ ₹1,695.404.8% of flowEquity SharesSEBI:7496e501f42a5963b4c20c44e2b4e738282069aa
- 37,590 shares@ ₹1,702.004.8% of flowEquity SharesSEBI:1a98deb4bd4169d7de364ac8f443971a0955ea43
- 25,000 shares@ ₹1,906.07214.0% of flowEquity SharesSEBI:e22eee6f384a27693948b9b62a25fa18c7e2f0ae
- 25,000 shares@ ₹1,825.003.8% of flowEquity SharesSEBI:73ef7acb1bd9faf73d6d865b5c3dc58e1874a864
- 25,000 shares@ ₹1,763.953.6% of flowEquity SharesSEBI:fd24bd48320d8a513e7102f2ef14238c8cfb833b
- 4,408 shares@ ₹1,670.48570.6% of flowEquity SharesSEBI:c4a21e0bf0e1e8ee8c6a80a31edf15931467d083
- 4,000 shares@ ₹1,693.37580.6% of flowEquity SharesSEBI:05cd0587a1e3aa7e65b159ad98418a17996edd3a
- 16,000 shares@ ₹1,680.652.2% of flowEquity SharesSEBI:4798255a6beeb18aa96d2a3ef2553e9f4d207acb
- 16,000 shares@ ₹1,708.402.2% of flowEquity SharesSEBI:ef293a051e5718b0aba1e490dad701ef9d6ec865
- 3,140 shares@ ₹2,106.15380.5% of flowEquity SharesSEBI:ad74092691688f38bf1aa8150b1cc870bf5ece14
- 2,500 shares@ ₹2,106.1540.4% of flowEquity SharesSEBI:7c467aa8aa68e4b6ad8660ee8a7dc65aa63a2aec
- 5,640 shares@ ₹2,106.15411.0% of flowEquity SharesSEBI:b0ff1d4b72ef5b9b455e8f4fc8ed15ff4665f2fe
- 5,640 shares@ ₹2,121.551.0% of flowEquity SharesSEBI:caf811a7fa640889741bba20ecb755aa889678f2
- 5,640 shares@ ₹1,952.000.9% of flowEquity SharesSEBI:f0bffc1d62dd7fee3ae83012e983b57115c4f9e8
- 11,200 shares@ ₹1,785.67861.8% of flowEquity SharesSEBI:6424aeb4c3b2602113f8d2f8e588b3fea523c7e9
- 11,200 shares@ ₹1,817.951.9% of flowEquity SharesSEBI:3f7a60277d0370116899d126f38bbcf5b69f24be
- 11,200 shares@ ₹1,792.451.8% of flowEquity SharesSEBI:b0f09bb80af37a4713ed4c962e6e88d03e43d351
24 of 24 declarations
